Item Type | Name |
Concept
|
Physical Therapy Modalities
|
Concept
|
Exercise Therapy
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Complementary Therapies
|
Concept
|
Treatment Outcome
|
Concept
|
Therapies, Investigational
|
Concept
|
Salvage Therapy
|
Concept
|
Combined Modality Therapy
|
Concept
|
Behavior Therapy
|
Concept
|
Treatment Failure
|
Concept
|
Antiretroviral Therapy, Highly Active
|
Academic Article
|
HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank.
|
Academic Article
|
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.
|
Academic Article
|
Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.
|
Academic Article
|
A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team.
|
Academic Article
|
Treatment of spasticity with botulinum toxin.
|
Academic Article
|
Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
|
Academic Article
|
Brain morphometric correlates of metabolic variables in HIV: the CHARTER study.
|
Academic Article
|
Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.
|
Academic Article
|
A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy.
|
Academic Article
|
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant.
|
Academic Article
|
Selected peripheral neuropathies associated with human immunodeficiency virus infection and antiretroviral therapy.
|
Academic Article
|
A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain.
|
Academic Article
|
Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
|
Academic Article
|
Effects of mandibular orthognathic treatment on mucogingival tissues.
|
Academic Article
|
Neurologic complications of AIDS: new concepts and treatments.
|
Academic Article
|
Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy.
|
Academic Article
|
Low atazanavir concentrations in cerebrospinal fluid.
|
Academic Article
|
Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study.
|
Academic Article
|
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy.
|
Academic Article
|
Non-institutional sources of assistance following a disaster: potential triage and treatment capabilities of neighborhood-based preparedness organizations.
|
Academic Article
|
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome?
|
Academic Article
|
Clinical factors related to brain structure in HIV: the CHARTER study.
|
Academic Article
|
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
|
Academic Article
|
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy.
|
Academic Article
|
Pilot study of intravenous immunoglobulin in HIV-associated myelopathy.
|
Academic Article
|
HIV-associated PML: changing epidemiology and clinical approach.
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders.
|
Academic Article
|
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors.
|
Academic Article
|
Challenges in developing novel therapies for peripheral neuropathies: a summary of The Foundation for Peripheral Neuropathy Scientific Symposium 2012.
|
Academic Article
|
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.
|
Academic Article
|
Treatment of myasthenia gravis by immunoadsorption of plasma.
|
Academic Article
|
Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.
|
Academic Article
|
HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment.
|
Academic Article
|
AIDS-associated vacuolar myelopathy.
|
Academic Article
|
Neuromuscular blockers.
|
Academic Article
|
Controlling neuropathic pain in HIV.
|
Academic Article
|
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.
|
Academic Article
|
Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention.
|
Academic Article
|
Persistent CSF but not plasma HIV RNA is associated with increased risk of new-onset moderate-to-severe depressive symptoms; a prospective cohort study.
|
Academic Article
|
Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity.
|
Academic Article
|
Therapeutic amprenavir concentrations in cerebrospinal fluid.
|
Academic Article
|
Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy.
|
Academic Article
|
OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors From a Delphi Panel Process.
|
Academic Article
|
Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial.
|
Academic Article
|
Journal of the Peripheral Nervous System. Supplement: Designing innovative therapies for neuropathic pain: 2014 FPN International Research Symposium. Introduction.
|
Academic Article
|
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy.
|
Academic Article
|
Neuromuscular complications of HIV infection and its treatment.
|
Academic Article
|
Self-poisoning and therapeutic intoxication with lithium.
|
Academic Article
|
Dark-field microscopic monitoring of subgingival bacteria during periodontal therapy.
|
Academic Article
|
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
White matter damage, neuroinflammation, and neuronal integrity in HAND.
|
Academic Article
|
Mirror therapy for improving lower limb motor function and mobility after stroke: A systematic review and meta-analysis.
|
Academic Article
|
Progressive sensory radiculopathy responsive to corticosteroid therapy.
|
Academic Article
|
Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy.
|
Academic Article
|
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
|
Academic Article
|
A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy.
|
Academic Article
|
Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
|
Academic Article
|
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
|
Academic Article
|
Role of metabolic syndrome components in HIV-associated sensory neuropathy.
|
Academic Article
|
NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials.
|
Academic Article
|
Neuromuscular complications of human immunodeficiency virus infection.
|
Academic Article
|
Spastic cocontraction in hemiparesis: effects of botulinum toxin.
|
Academic Article
|
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
|
Academic Article
|
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
|
Academic Article
|
Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: the BRIGHT study.
|
Academic Article
|
The cerebrospinal fluid HIV risk score for assessing central nervous system activity in persons with HIV.
|
Academic Article
|
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.
|
Academic Article
|
Experience and challenges presented by a multicenter crossover study of combination analgesic therapy for the treatment of painful HIV-associated polyneuropathies.
|
Academic Article
|
NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
|
Academic Article
|
Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy.
|
Academic Article
|
Designing innovative therapies for neuropathic pain: preclinical and early clinical development challenges.
|
Academic Article
|
Phase 1 study of the selective BTK inhibitor zanubrutinib in B-cell malignancies and safety and efficacy evaluation in CLL.
|
Academic Article
|
Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA.
|
Academic Article
|
Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.
|
Academic Article
|
Ibrutinib for the treatment of Bing-Neel syndrome: a multicenter study.
|
Academic Article
|
Mirror therapy and treadmill training for patients with chronic stroke: a pilot randomized controlled trial.
|
Academic Article
|
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
|
Academic Article
|
A pilot study of L-methionine for the treatment of AIDS-associated myelopathy.
|
Academic Article
|
Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial. AIDS Clinical Group 175/801 Study Team.
|
Academic Article
|
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.
|
Academic Article
|
Traditional pharmacological treatments for spasticity. Part I: Local treatments.
|
Academic Article
|
An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
|
Academic Article
|
Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
|
Academic Article
|
Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients.
|
Academic Article
|
Laparoscopic splenectomy and the treatment outcomes for idiopathic thrombocytopaenic purpura at North Shore Hospital.
|
Academic Article
|
AIDS and AIDS-treatment neuropathies.
|
Academic Article
|
AIDS and AIDS-treatment neuropathies.
|
Academic Article
|
Clinical trials of botulinum toxin in the treatment of spasticity.
|
Academic Article
|
Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. The Peptide T Neuropathy Study Group.
|
Academic Article
|
Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome.
|
Academic Article
|
Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.
|
Academic Article
|
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
|
Academic Article
|
Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
|
Academic Article
|
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
|
Academic Article
|
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
|
Academic Article
|
A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework.
|
Academic Article
|
Hypnosis for treatment of HIV neuropathic pain: a preliminary report.
|
Academic Article
|
Management and outcomes of axial isolated distal deep vein thrombosis at North Shore Hospital, New Zealand: a retrospective audit.
|
Academic Article
|
Contralateral weakness following botulinum toxin for poststroke spasticity.
|
Academic Article
|
Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.
|
Academic Article
|
Hemochromatosis (HFE) Gene Variants Are Associated with Increased Mitochondrial DNA Levels During HIV-1 Infection and Antiretroviral Therapy.
|
Academic Article
|
OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a?Delphi Panel Approach.
|
Academic Article
|
Poster 354 OnabotulinumtoxinA to Treat Common Postures in Post-Stroke Lower Limb Spasticity: Identification of a Treatment Paradigm.
|
Academic Article
|
Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.
|
Academic Article
|
Progressive multifocal leukoencephalopathy in AIDS: are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team.
|
Academic Article
|
Safety and clinical effects of topical histatin gels in humans with experimental gingivitis.
|
Academic Article
|
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
|
Academic Article
|
Treatment of AIDS-associated myelopathy with L-methionine: a placebo-controlled study.
|
Academic Article
|
HIV-related neurocognitive impairment in the HAART era.
|
Academic Article
|
Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort.
|
Academic Article
|
Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings.
|
Academic Article
|
Treatment of painful distal sensory polyneuropathy in HIV-infected patients with a topical agent: results of an open-label trial of 5% lidocaine gel.
|
Academic Article
|
A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.
|
Academic Article
|
Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
|
Academic Article
|
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
|
Academic Article
|
Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.
|
Academic Article
|
Contextual factors and anxiety in minority and European American youth presenting for treatment across two urban university clinics.
|
Academic Article
|
Genetic variation in iron metabolism is associated with neuropathic pain and pain severity in HIV-infected patients on antiretroviral therapy.
|
Academic Article
|
The roles of ethnicity and antiretrovirals in HIV-associated polyneuropathy: a pilot study.
|
Academic Article
|
Safety profile of treatment in diabetic peripheral neuropathic pain.
|
Academic Article
|
Adapting stepped care: Changes to service delivery format in the context of high demand.
|
Academic Article
|
Neural Reactivity to Angry Faces Predicts Treatment Response in Pediatric Anxiety.
|
Academic Article
|
Management of Neuropathic Pain in the Geriatric Population.
|
Academic Article
|
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults.
|
Academic Article
|
Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study.
|
Academic Article
|
Dose-Dependent Effects of AbobotulinumtoxinA (Dysport) on Spasticity and Active Movements in Adults With Upper Limb Spasticity: Secondary Analysis of a Phase 3 Study.
|
Academic Article
|
Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial.
|
Academic Article
|
HIV neuropathy.
|
Academic Article
|
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.
|
Academic Article
|
Management and outcomes of single subsegmental pulmonary embolus: a retrospective audit at North Shore Hospital, New Zealand.
|
Academic Article
|
Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
|
Academic Article
|
Botulinum Toxin Therapy in Writer's Cramp and Musician's Dystonia.
|
Academic Article
|
Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies.
|
Academic Article
|
Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
|
Academic Article
|
The role of the capsaicin 8% patch in the treatment of painful diabetic peripheral neuropathy.
|
Academic Article
|
Zanubrutinib for treatment-na?ve and relapsed/refractory chronic lymphocytic leukaemia: long-term follow-up of the phase I/II AU-003 study.
|
Grant
|
NEUROMUSCULAR DISORDERS IN HIV INFECTION AND ROLE OF AZT
|
Grant
|
MIDCAREER INVESTIGATOR AWARD IN NEURO-AIDS RESEARCH
|
Academic Article
|
Changes in cerebral autoregulation, stroke-related blood biomarkers, and autonomic regulation after patent foramen ovale closure in severe migraine patients.
|